The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hi NG, you have been pretty bullish on your estimate of the sp this year (between £35 to £52, I recall from an old post). Do you still think the same given recent news or given the uncertainties SNN has mentioned and reduction in wholesale price reducing T/O have you revised your personal goals. DMOR and all that! Thanks for considering the question. N
I could've made tens of thousands on this share simply by selling this at a peak and buying back when the price plunges, which always happens, particularly when there's amazing news. I have said before, I don't understand this share. No-one understands why it's so undervalued. I found SP Angel and Liberum mixed, whilst at the same time giving a target price of over 16 quid, which I have no doubt will be reached at some point. Somehow, they found a negative outlook in a rosy picture. Am I just kidding myself that this will be £35 one day?
It's good to see the share price sticking above £10, no matter what. I tend to still think it is undervalued. I can realistically see this getting up to £30 over the next 2 or 3 of years if the current trajectory is maintained. Divis need to be markedly increased over that period too.
To be fair, the Company share price tanked from £12 to around 57p and Bobby has admitted he took his eyes off the road and they grew too quickly. You need risk takers, it's a good thing, if you have balance. I am looking to explain why, given the numbers the share hasn't taken off (the shares were worth £12 years ago with a much smaller business). We all saw the presentation. What's the explanation for it? My sense is that IIs are unconvinced by management.
Don't misunderstand me, I'd love this share to be trading higher - as it rightfully should be.
I thought the presentation earlier this week was okay; a bit lackluster. Bobby's answer to where do you see Yu in 3 year's time was a politician's answer and so was unconvincing. This was a chance to leave us in high spirits with fire in our bellies, but we just got an asinine boilerplate nothing answer. Disappointing. Bobby seems like a risktaker to me, as entrepreneurs should be. He needs someone forceful by his side to keep him in line, is my guess. I am not sure that he has those checks and the 2018 debacle might suggest that he's historically been light on the granular detail.
As a long term holder, I have come to the conclusion that this share is being used and an income share; sell and buy back. I would have made tonnes if I had, had this approach. Just when you think the rise in inexorable it drops a couple of quid. I could've bought a new car this week if I had that approach, but haven't, sadly! :(
In the next 6 months, I am hoping we get a base somewhere nearer £14 and maybe £15 to £17 in the next 18 months. This would seem to be entirely realistic to me. That's still a great investment for current non-holders.
I am less sure about the share being with £94 on a 12x EPS in FY25, although, clearly we'd all love that! If the company's investor roadshows were an uninspiring as the CMI presentation this week, I can see why institutions are not all piling in; there may be lingering doubts around management. The numbers are great and have huge potential., assuming nothing has been mucked up. The comms suck.